I'm LongbridgeAI, I can summarize articles.Endava PLC reported disappointing Q3 results, with earnings of 7 cents per share and sales of $240.662 million, both missing analyst expectations. The company lowered its FY26 guidance for EPS and sales. In response, analysts downgraded the stock, with JP Morgan cutting its price target from $9 to $5, while Morgan Stanley and TD Cowen also reduced their targets. Endava shares fell 2.4% to $3.25.
Endava PLC – ADR (NYSE:DAVA) on Thursday reported worse-than-expected third-quarter financial results and cut its FY26 guidance below estimates.
Endava reported quarterly earnings of 7 cents per share which missed the analyst consensus estimate of 20 cents per share. The company reported quarterly sales of $240.662 million which missed the analyst consensus estimate of $249.690 million.
Endava cut its FY2026 adjusted EPS guidance from $1.10-$1.18 to $0.61-$0.66 and also lowered sales guidance from $1.008 billion-$1.028 billion to $972.956 million-$978.348 million.
“This has been one of the more challenging periods Endava has faced in recent years. Demand remains uneven across sectors, deal cycles continue to be extended, and clients are scrutinizing technology spending more carefully than at any point since the macro slowdown began. Against this backdrop, revenue came in below expectations, margin contracted, and we recognized a non-cash goodwill impairment," said John Cotterell, Endava’s CEO.
Endava shares fell 2.4% to trade at $3.25 on Friday.
These analysts made changes to their price targets on Endava following earnings announcement.
- JP Morgan analyst Puneet Jain downgraded Endava from Neutral to Underweight and cut the price target from $9 to $5.
- Morgan Stanley analyst James Faucette maintained the stock with an Equal-Weight rating and lowered the price target from $8 to $4.
- TD Cowen analyst Bryan Bergin maintained Endava with a Hold and lowered the price target from $6 to $4.
Considering buying DAVA stock? Here’s what analysts think:
Photo via Shutterstock